BRAF and non-small cell lung carcinoma: In our present multi-center study, we retrospectively analyzed the next-generation sequencing data of 8405 Chinese NSCLC patients from 5 cancer centers to survey the prevalence of BRAF mutations, to investigate the distribution of BRAF mutations according to the new functional classification system, and to analyze the association between functional class and clinical features in this population.